SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14F1 - Statement regarding change in majority of directors [Rule 14f-1]:
SEC Accession No. 0001213900-21-038393
Filing Date
2021-07-23
Accepted
2021-07-23 17:00:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14F-1 ea144625-sc14f1_boston.htm SC 14F1 135485
  Complete submission text file 0001213900-21-038393.txt   137262
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Filed by) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14F1
SIC: 2834 Pharmaceutical Preparations

Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Subject) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14F1 | Act: 34 | File No.: 005-87827 | Film No.: 211111495
SIC: 2834 Pharmaceutical Preparations